In young patients with a normal karyotype and no FLT3-ITD mutation, the prognosis is comparable with that of patients with AML with t(8;21)(q22;q22.1) or AML with inv(16)(p13.1;q22) [54]. This evidence concerns the gene FLT3 and acute myeloid leukemia.